Table 2: HBM and vaccination status/intention to receive the vaccine of swine-flu/influenza-virus.
Constructs of HBM | Teitler-Regev S, et al. 14 | Taylor P, et al. 16 | Nexøe J, et al. 18 | ||||||
---|---|---|---|---|---|---|---|---|---|
Constructs of HBM | OR | 95% CI | P-value | OR | 95% CI | P-value | OR | 95% CI | P-value |
Susceptibility | 0.23 | - | 0.01 | 0.13 | - | < 0.05 | - | - | - |
Severity | 0.18 | - | 0.01 | 0.05 | - | >0.05 | 1.11 | 1.07-1.15 | 0.000 |
Risk | 0.47 | - | 0.04 | - | - | - | - | - | - |
Self-efficacy | - | - | - | 0.07 | - | >0.05 | - | - | - |
Benefits | 0.7 | - | 0.43 | 0.27 | - | <0.001 | 1.64 | 1.31-2.03 | 0.000 |
Barrier | 0.32 | - | 0.01 | 0.04 | - | >0.05 | 0.89 | 0.85-0.94 | 0.000 |
Cues to action (Health promotion) | 1.3 | - | 0.55 | - | - | - | - | - | - |